Loading company filing…
Find a company. Follow its revenue through costs and profit.
Coverage includes separate ticker and security records; counts are not unique companies.
Sankey diagram of FunPep Company Limited. A complete text table follows the diagram.
R&D accounts for nearly 80% of disclosed business expenses as the biotech company remains deeply loss-making.
Swipe to explore
Every category amount is a reported EDINET XBRL fact. Nodes described as arithmetic bridges are calculated residuals and do not imply a separately reported filing line.
Labels and narrative explain the filing. A category marked “arithmetic bridge” or “residual” is calculated from reported totals, rather than a separately reported line.
| Category | Stage | Value | Notes |
|---|---|---|---|
| Research & development expenses | 1 | 726M | 79.8% of reported total |
| Other selling, general & administrative expenses | 1 | 184M | 20.2% of reported total |
| Business expenses | 2 | 910M | Reported six-month total · ¥910M |
| Operating loss | 2 | 910M | Absolute value of reported operating loss |
| Operating costs & expenses | 3 | 1.8B | Revenue plus reported operating loss |
| From | To | Value |
|---|---|---|
| Research & development expenses | Business expenses | 726M |
| Other selling, general & administrative expenses | Business expenses | 184M |
| Business expenses | Operating costs & expenses | 910M |
| Operating loss | Operating costs & expenses | 910M |